Kelch Mutations in Plasmodium falciparum Protein K13 Do Not Modulate Dormancy after Artemisinin Exposure and Sorbitol Selection In Vitro

  • Kimberly F. Breglio
  • , Rifat S. Rahman
  • , Juliana M. Sá
  • , David J. Roberts
  • , Thomas E. Wellems*
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

17 Citations (Scopus)

Abstract

Some Kelch mutations of the Plasmodium falciparum K13 protein confer increased survival to dihydroartemisinin (DHA)-treated ring-stage parasites. Here, we asked if K13 mutations affect a dormancy phenotype allowing parasites to survive DHA exposure and then sorbitol selection. Although recrudescence from dormancy differed between two distinct parasite lines, it was similar for isogenic lines carrying single-site substitutions in K13. Therefore, K13 mutations do not alter the DHA-sorbitol combined dormancy phenotype; rather, traits from other loci likely determine this phenotype.

Original languageEnglish
Article numbere02256-17
JournalAntimicrobial Agents and Chemotherapy
Volume62
Issue number5
DOIs
Publication statusPublished - May 2018
Externally publishedYes

Bibliographical note

Publisher Copyright:
Copyright © 2018 American Society for Microbiology. All Rights Reserved.

Keywords

  • Drug resistance
  • Malaria
  • Recrudescence

Fingerprint

Dive into the research topics of 'Kelch Mutations in Plasmodium falciparum Protein K13 Do Not Modulate Dormancy after Artemisinin Exposure and Sorbitol Selection In Vitro'. Together they form a unique fingerprint.

Cite this